PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.9906
+0.4053 (69.25%)
At close: Sep 16, 2026, 4:00 PM EDT
0.9301
-0.0605 (-6.11%)
After-hours: Sep 16, 2026, 6:37 PM EDT
PDS Biotechnology Employees
PDS Biotechnology had 21 employees as of December 31, 2025. The number of employees decreased by 3 or -12.50% compared to the previous year.
Employees
21
Change (1Y)
-3
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$1,603,427
Market Cap
55.45M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 21 | -3 | -12.50% |
| Dec 31, 2024 | 24 | -1 | -4.00% |
| Dec 31, 2023 | 25 | -1 | -3.85% |
| Dec 31, 2022 | 26 | 4 | 18.18% |
| Dec 31, 2021 | 22 | 7 | 46.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Palatin Technologies | 29 |
| Jasper Therapeutics | 22 |
| Lantern Pharma | 16 |
| Psyence Biomedical | 12 |
| Cellectar Biosciences | 11 |
| Cocrystal Pharma | 10 |
| Akari Therapeutics, | 6 |
PDSB News
- 2 days ago - PDS Biotechnology announces initial closing of up to $22.3M PIPE financing - TheFly
- 2 days ago - PDS Biotechnology names Soon-Shiong, James Banaag to board of directors - TheFly
- 2 days ago - PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors - GlobeNewsWire
- 8 days ago - PDS Biotechnology price target lowered to $5 from $7 at H.C. Wainwright - TheFly
- 8 days ago - PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks - GlobeNewsWire
- 4 weeks ago - PDS Biotechnology reports Q2 EPS (18c), consensus (13c) - TheFly
- 4 weeks ago - PDS Biotechnology price target lowered to $7 from $15 at H.C. Wainwright - TheFly
- 4 weeks ago - PDS Biotech Reports Second Quarter 2026 Financial Results - GlobeNewsWire